Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT06092736

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06092736
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06092736. Randomized; quadruple masking; primary purpose treatment. Start 2018-12-18 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
Acronym
MAIDS
Condition
Microvascular Angina
Intervention (Drug)
Compound Danshen Dropping Pills
Intervention (Drug)
Placebo
Lead sponsor
Qilu Hospital of Shandong University (class: other)

Record details

Record id
cardio:ct-nct06092736
Content hash
c19842248264bc0173f84d65efbdfbb033ee12b6c406ea264e5a2ef1aba3de72